-
公开(公告)号:US10894037B2
公开(公告)日:2021-01-19
申请号:US16233280
申请日:2018-12-27
Applicant: Academia Sinica
Inventor: Chinpan Chen , Tien-Sheng Tseng , Keng-Chang Tsai
IPC: A61K31/422 , A61K45/06 , A61K31/385
Abstract: Disclosed herein are novel uses of a compound of formula (I) as an inhibitor of bacterial two component signal transduction system (TCS), A-L-B-L-A (I) wherein, A is a moiety having a negative charge; L is —(C2H5—O)n—CH2— or a moiety consists of a carbocyclyl and a heterocyclyl respectively having 5 to 10 ring atoms and coupling together, in which n is 0 or 1; and B is a 5 to 10-membered carbocyclyl or heterocyclyl. The compound of formula (I) may suppress or inhibit the growth of bacteria, including the notorious multi-drug resistant bacteria.
-
公开(公告)号:US10793628B2
公开(公告)日:2020-10-06
申请号:US15322788
申请日:2015-06-30
Applicant: Academia Sinica
Inventor: Wen-Hwa Lee , Jin-Yuh Shew , Che Ma , Chia-Lin Chen , Wen-Hsin Lee , Chun-Kai Huang , Heng-Hsiung Wu
IPC: A61K39/395 , C07K16/24 , A61K45/06 , A61K31/713 , A61K38/20 , C07K16/28 , C07K16/30 , A61P35/00 , C07K14/715 , C12N15/113 , A61K39/00
Abstract: Methods and compositions for treatment and therapy of cancer are provided. Specifically, antagonists specific for interleukin-17 receptor B (IL-17RB) and its ligand IL-17B are provided. Potent neutralizing antibodies specific for IL-17RB and methods for their manufacture and use are disclosed. The invention also relates to antisense, RNAi and shRNA compositions for the prevention and treatment of cancer, in particular breast cancer and pancreatic cancer.
-
公开(公告)号:US10765681B2
公开(公告)日:2020-09-08
申请号:US16075202
申请日:2017-02-03
Applicant: Academia Sinica , National Taiwan University
Inventor: Chi-Huey Wong , Pan-Chyr Yang , Jim-Min Fang , Szu-Hua Pan , Ting-Jen R. Cheng , Ling-Wei Li
IPC: C07D473/00 , A61K31/522 , A61K45/06 , A61K31/337 , A61K31/52 , A61K31/506 , A61K31/502 , A61K31/167 , A61K31/454 , A61K38/05 , A61K31/517 , A61K31/4025 , A61K31/5377 , A61K31/69 , A61K31/44 , A61K35/00
Abstract: The present disclosure provides compounds of Formulas (I′) and (I), and pharmaceutically acceptable salts thereof. The compounds described herein may be useful in treating and/or preventing proliferative diseases (e.g., cancer). Also provided in the present disclosure are pharmaceutical compositions, kits, and uses thereof for treating proliferative diseases.
-
公开(公告)号:US20200179503A1
公开(公告)日:2020-06-11
申请号:US16442334
申请日:2019-06-14
Applicant: Academia Sinica
Inventor: Shih-Hsiung Wu , Chung-Yi Wu , I-Ming Lee , Feng-Ling Yang
Abstract: Disclosed herein is a glycocojugate vaccine conferring protection against a Gram negative pathogen infection, a method of manufacturing the glycoconjugate vaccine, and use of the glycocojugate vaccine for treating bacterial infection. The glycocojugate vaccine of the present disclosure has the structure of formula (I), wherein, L is a maleimide-type linker, which is connected to the carrier protein via a maleimide bond formed therebetween; and n and m are respectively an integral or a non-integral number between 2 and 20.
-
公开(公告)号:US10577620B2
公开(公告)日:2020-03-03
申请号:US16178702
申请日:2018-11-02
Applicant: ACADEMIA SINICA
Inventor: Hsou-Min Li , Chiung-Chih Chu
IPC: C12N15/82
Abstract: The present invention provides a recombinant DNA molecule encoding a fusion protein, comprising a first DNA sequence encoding a high-efficiency transit peptide operably linked to a second DNA sequence encoding a passenger protein, wherein the high-efficiency transit peptide is selected from the group consisting of transit peptides of the precursors of translocon at the inner envelope membrane of chloroplasts 40 kD (prTic40), chaperonin 10-2 (prCpn10-2), Fibrillin 1B (prFibrillin), ATP sulfurylase 1 (prAPS1), ATP sulfurylase 3 (prAPS3), 5′-adenylylsulfate reductase 3 (prAPR3), stromal ascorbate peroxidase (prsAPX), prTic40-E2A (a prTic40 variant), prCpn10-1-ΔC7C37S (a chaperonin 10-1 variant), a functional fragment of any of the transit peptides and an equivalent thereof. And the present invention also provides a method of high efficiency delivery of a protein into plastids using the high-efficiency transit peptides.
-
公开(公告)号:US20200010898A1
公开(公告)日:2020-01-09
申请号:US16491163
申请日:2018-03-15
Applicant: Academia Sinica
Inventor: Shie-Liang HSIEH , Ya-Lang HUANG , Tsung-Yu TSAI
IPC: C12Q1/6883 , G01N33/566 , G01N33/576 , C12Q1/70
Abstract: Disclosed herein is a novel use of C-type lectin 18 (CLEC18) in disease prognosis. According to embodiments of the present disclosure, the mRNA or protein level of CLEC18 may serve as an indicator for diagnosing hepatitis B virus (HBV) infection, hepatitis B e antigen (HBeAg) loss and seroconversion, and/or liver fibrosis.
-
67.
公开(公告)号:US10408813B2
公开(公告)日:2019-09-10
申请号:US15136016
申请日:2016-04-22
Applicant: Academia Sinica
Inventor: Klim King , Yu-Heng Cheng
IPC: G01N1/00 , G01N33/483 , A61K31/164 , A61K31/231
Abstract: Cyclic adenosine monophosphate (cAMP) biosensors comprising a Renilla luciferase (RLuc), a green fluorescent protein (GFP), and an exchange protein activated by cAMP, and uses thereof in determining cAMP levels both in vivo and in vitro. Another aspect of the invention relates to methods for controlling blood glucose levels.
-
公开(公告)号:US20190263893A1
公开(公告)日:2019-08-29
申请号:US16409994
申请日:2019-05-13
Applicant: Academia Sinica
Inventor: An-Suei YANG , Hong-Sen CHEN , Ing-Chien CHEN , Chao-Ping TUNG , Shin-Chen HOU , Chung-Ming YU , Chi-Kai YANG , Yi-Kai CHIU
Abstract: Disclosed herein is a phage-displayed single-chain variable fragment (scFv) library, that comprised a plurality of phage-displayed scFvs characterized with (1) a specific CS combination; (2) a specific distribution of aromatic residues in each CDR; and (3) a specific sequence in each CDR. The present scFv library could be used to efficiently produce different antibodies with binding affinity to different antigens. Accordingly, the present disclosure provides a potential means to generate different antigen-specific antibodies promptly in accordance with the need in experimental researches and/or clinical applications.
-
公开(公告)号:US20190239515A1
公开(公告)日:2019-08-08
申请号:US16389147
申请日:2019-04-19
Applicant: Academia Sinica
Inventor: Yet-Ran Chen , Ying-Lan Chen , Mei-Chun Tseng
IPC: A01N65/38 , C12N15/82 , C07K14/415
CPC classification number: A01N65/38 , A61K38/00 , C07K14/415 , C12N15/8271 , C12N15/8279
Abstract: The present invention related to a novel plant defense signaling peptide and applications thereof.
-
公开(公告)号:US10342818B2
公开(公告)日:2019-07-09
申请号:US14849782
申请日:2015-09-10
Applicant: Academia Sinica
Inventor: Yun-Lian Lin , Yijuang Chern , Jim-Min Fang , Jung-Hsing Lin , Nai-Kuei Huang
IPC: A01N43/04 , A61K31/70 , A61K31/7076 , C07H19/167 , A61K31/706 , A61K31/7064
Abstract: The present invention provides therapeutic agents for preventing and treating neurodegenerative diseases. These agents synergistically target both the adenosine A2A receptor (A2AR) and the equilibrative nucleoside transporter 1 (ENT1).
-
-
-
-
-
-
-
-
-